Unterehmen auf Watchlist setzen
Blueprint Medicines
ISIN: US09627Y1091
WKN: A14SDD
Über
Unternehmensprofil
Tipp: Investor-Alerts aktivieren
Lassen Sie sich bei neuen Publikationen informieren
Tipp: AI-Factsheet

Corporate News meets AI! 
Analyse der Inhalte und Zusammenfassung

Blueprint Medicines · ISIN: US09627Y1091 · PR Newswire (ID: 20240724LA68434)
24 Juli 2024 04:45PM

Investors Have the Opportunity to Join the Following Securities Fraud Investigations: Avangrid, Inc. (AGR), Squarespace, Inc. (SQSP), and Blueprint Medicines Corporation (BPMC)


LOS ANGELES, July 24, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors in Avangrid, Inc. ("Avangrid" or "the Company") (NYSE: AGR), Squarespace, Inc. ("Squarespace" or "the Company") (NYSE: SQSP), and Blueprint Medicines Corporation ("Blueprint" or "the Company") (NASDAQ: BPMC), for potential breaches of fiduciary duty on the part of their directors and management.

PowerSchool (NYSE: PWSC)

The investigation focuses on determining if the PowerSchool board breached its fiduciary duties to shareholders.

If you are a shareholder, click here to participate.

Squarespace, Inc. (NYSE: SQSP)

The investigation focuses on determining if the SquareSpace board breached its fiduciary duties to shareholders. SquareSpace announced on May 13, 2024, that private equity firm Premira would take it private in an all-cash deal valued at $6.9 billion, with a offer of $44 per share.

If you are a shareholder, click here to participate.

Blueprint Medicines Corporation (NASDAQ: BPMC)

The investigation focuses on determining if the Blueprint board breached its fiduciary duties to shareholders.

If you are a shareholder, click here to participate.

We also encourage you to contact Brian Schall of the Schall Law Firm, 2049 Century Park East, Suite 2460, Los Angeles, CA 90067, at 310-301-3335, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at bschall@schallfirm.com.

The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.

This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.

CONTACT:

The Schall Law Firm 

Brian Schall, Esq.

310-301-3335

info@schallfirm.com

www.schallfirm.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/investors-have-the-opportunity-to-join-the-following-securities-fraud-investigations-avangrid-inc-agr-squarespace-inc-sqsp-and-blueprint-medicines-corporation-bpmc-302204892.html

SOURCE The Schall Law Firm

Visuelle Wertentwicklung / Kursverlauf · Blueprint Medicines
Smarte Analyse- und Recherchewerkzeuge finden Sie hier.
This publication was provided by our content partner PR Newswire
PR Newswire
via PR Newswire - Newsfeed
Cision ©2024
PR Newswire
Kontakt:
300 S Riverside Plaza, Chicago, Illinois, USA
+001 (0) 888-776-0942